Pseudomonas skin infection: clinical features, epidemiology, and management.
about
Pseudomonas aeruginosa directly shunts β-oxidation degradation intermediates into de novo fatty acid biosynthesisSubtilase SprP exerts pleiotropic effects in Pseudomonas aeruginosaDeletion mutant library for investigation of functional outputs of cyclic diguanylate metabolism in Pseudomonas aeruginosa PA14.Evolution of Pseudomonas aeruginosa virulence as a result of phage predation.Mycobacterium ulcerans fails to infect through skin abrasions in a guinea pig infection model: implications for transmission.Healthcare-associated viral and bacterial infections in dentistry.Arginine-rich self-assembling peptides as potent antibacterial gelsIn vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.Microbiology of the skin and the role of biofilms in infection.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.A proof-of-concept model for the identification of the key events in the infection process with specific reference to Pseudomonas aeruginosa in corneal infections.Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.Cranberry-derived proanthocyanidins impair virulence and inhibit quorum sensing of Pseudomonas aeruginosa.Green nail syndrome treated with the application of tobramycin eye drop.Characterization of the multiple molecular mechanisms underlying RsaL control of phenazine-1-carboxylic acid biosynthesis in the rhizosphere bacterium Pseudomonas aeruginosa PA1201.The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa.In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design.Environmental Reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa.Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
P2860
Q28492854-31743B02-FF1E-4EA0-8469-C2ADE626EDC4Q28492963-50E70F64-41F1-4DE8-8592-EF980F79A0E2Q33601771-ED3ACB45-E4E4-4963-AA5A-347BC743832BQ34871061-761449A0-4C9A-4A7C-B3C7-EABABA159FF3Q35145362-9806FFD2-16A7-438D-A500-E81AB7F238F5Q36031869-A3A9CA50-7750-4E47-820C-52505E221EE3Q36303722-79346D7A-F63F-4416-9E61-15E39994A9B4Q36893415-AB355212-6701-4E03-91EB-69B867BB130EQ37942623-BC02DD06-41EF-4255-8E11-D36B8FCEC3D0Q38599969-005FF84C-7BF2-42DC-BEBB-6C0B6935AAA8Q38627617-668A50AD-50B7-4E75-849C-40F88C0ADAA8Q39331661-56F24DD9-E4E3-4B93-91E3-DACFF770E28FQ40583603-E23B40DC-D75A-41AE-B028-98239634AA4FQ42088282-DCE1B10B-4C79-4C8F-9FF4-CDAE427B35E4Q46402087-78268562-65F6-49C3-AB09-77DCABF32E14Q51577812-218115EE-F434-45B9-8815-274B6378E772Q52691351-94596413-C590-41C9-9B41-A3D9AC72FCBFQ52717154-5242DE8B-F852-4E7D-850E-9FF62C7F8A46Q54216766-90E5B649-A7EE-40FA-82B5-5628261F1B49
P2860
Pseudomonas skin infection: clinical features, epidemiology, and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pseudomonas skin infection: clinical features, epidemiology, and management.
@en
Pseudomonas skin infection: clinical features, epidemiology, and management.
@nl
type
label
Pseudomonas skin infection: clinical features, epidemiology, and management.
@en
Pseudomonas skin infection: clinical features, epidemiology, and management.
@nl
prefLabel
Pseudomonas skin infection: clinical features, epidemiology, and management.
@en
Pseudomonas skin infection: clinical features, epidemiology, and management.
@nl
P2093
P2860
P1476
Pseudomonas skin infection: clinical features, epidemiology, and management.
@en
P2093
Andrei I Metelitsa
Andrew N Lin
Douglas C Wu
Loretta Fiorillo
Wilson W Chan
P2860
P304
P356
10.2165/11539770-000000000-00000
P577
2011-06-01T00:00:00Z